JAGUAR HEALTH, INC. Preferred Stock, Shares Issued
JAGUAR HEALTH, INC. (JAGX) had Preferred Stock, Shares Issued of 1.12 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Equity › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesIssued · last filed 2026-08-19
- 2026-06-30: Preferred Stock, Shares Issued 1.12K shares.
- 2026-03-31: Preferred Stock, Shares Issued 0.00 shares.
- 2025-12-31: Preferred Stock, Shares Issued 275.00 shares.
- 2025-09-30: Preferred Stock, Shares Issued 1.33K shares.
| Period end | Preferred Stock, Shares Issued |
|---|---|
| 2026-06-30 | 1.12K shares 10-Q · filed 2026-08-19 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-20 |
| 2025-12-31 | 275.00 shares 10-Q · filed 2026-08-19 |
| 2025-09-30 | 1.33K shares 10-Q · filed 2025-11-14 |
| 2025-06-30 | 381.00 shares 10-Q · filed 2025-08-14 |
| 2025-03-31 | 99.00 shares 10-Q · filed 2025-05-15 |
| 2024-12-31 | 99.00 shares 10-K · filed 2026-04-07 |
| 2024-09-30 | 99.00 shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 99.00 shares 10-Q · filed 2024-08-13 |
| 2024-03-31 | 99.00 shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 178.00 shares 10-K · filed 2025-03-31 |
| 2023-09-30 | 335.00 shares 10-Q · filed 2023-11-14 |
| 2023-06-30 | 242.00 shares 10-Q · filed 2023-08-14 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-15 |
| 2022-12-31 | 0.00 shares 10-Q · filed 2023-11-14 |
| 2021-12-31 | 0.00 shares 10-K · filed 2023-03-24 |
| 2020-09-30 | 857.05K shares 10-Q · filed 2020-11-16 |
| 2019-12-31 | 5.54M shares 10-K · filed 2021-03-31 |
| 2017-12-31 | 0.00 shares 10-K · filed 2018-04-09 |
| 2017-09-30 | 0.00 shares 10-Q · filed 2017-11-20 |
| 2017-06-30 | 0.00 shares 10-Q · filed 2017-08-09 |
| 2017-03-31 | 0.00 shares 10-Q/A · filed 2017-06-23 |
| 2016-12-31 | 0.00 shares 10-K · filed 2018-04-09 |
| 2016-09-30 | 0.00 shares 10-Q · filed 2016-11-14 |
| 2016-06-30 | 0.00 shares 10-Q · filed 2016-08-15 |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-10 |
| 2015-12-31 | 0.00 shares 10-K · filed 2017-02-15 |
| 2014-12-31 | 0.00 shares 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |